JNJ-73763924

N/A

Report date: 2025/07/20 20:00:04
NME

Base Information

Drug NameJNJ-73763924
Drug Alias NameJNJ-73763924
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsHepatitis B virus
Therapy Area/IndicationsHepatitisHepatic Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Sciences Ireland Uc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Sciences Ireland Uc
Inactive CompaniesN/A
Active IndicationsHepatitis
Inactive IndicationsHepatic Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A